172 related articles for article (PubMed ID: 10725801)
21. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.
Mitchell LA; Pearson TW; Gauldie J
Immunology; 1986 Feb; 57(2):291-6. PubMed ID: 3485076
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide synthesis is depressed in Bos indicus cattle infected with Trypanosoma congolense and Trypanosoma vivax and does not mediate T-cell suppression.
Taylor K; Lutje V; Mertens B
Infect Immun; 1996 Oct; 64(10):4115-22. PubMed ID: 8926077
[TBL] [Abstract][Full Text] [Related]
23. TLR-2 and MyD88-Dependent Activation of MAPK and STAT Proteins Regulates Proinflammatory Cytokine Response and Immunity to Experimental
Kuriakose S; Onyilagha C; Singh R; Olayinka-Adefemi F; Jia P; Uzonna JE
Front Immunol; 2019; 10():2673. PubMed ID: 31824484
[TBL] [Abstract][Full Text] [Related]
24. Altered proinflammatory cytokine production and enhanced resistance to Trypanosoma congolense infection in lymphotoxin beta-deficient mice.
Okwor I; Muleme H; Jia P; Uzonna JE
J Infect Dis; 2009 Aug; 200(3):361-9. PubMed ID: 19563258
[TBL] [Abstract][Full Text] [Related]
25. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of self-cure from Trypanosoma congolense infection in mice.
Pinder M; Chassin P; Fumoux F
J Immunol; 1986 Feb; 136(4):1427-34. PubMed ID: 3484768
[TBL] [Abstract][Full Text] [Related]
27. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation.
Shi MQ; Wang CR; Wei GJ; Pan WL; Appleyard G; Tabel H
Parasite Immunol; 2006 Dec; 28(12):643-7. PubMed ID: 17096643
[TBL] [Abstract][Full Text] [Related]
28. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Hertz CJ; Mansfield JM
Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
[TBL] [Abstract][Full Text] [Related]
29. Resistance to the African trypanosomes is IFN-gamma dependent.
Hertz CJ; Filutowicz H; Mansfield JM
J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
[TBL] [Abstract][Full Text] [Related]
30. IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice.
Bosschaerts T; Morias Y; Stijlemans B; Hérin M; Porta C; Sica A; Mantovani A; De Baetselier P; Beschin A
Eur J Immunol; 2011 Nov; 41(11):3270-80. PubMed ID: 21805465
[TBL] [Abstract][Full Text] [Related]
31. Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells.
Shi M; Wei G; Pan W; Tabel H
J Leukoc Biol; 2004 Aug; 76(2):399-405. PubMed ID: 15136584
[TBL] [Abstract][Full Text] [Related]
32. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response.
Das L; Datta N; Bandyopadhyay S; Das PK
J Immunol; 2001 Mar; 166(6):4020-8. PubMed ID: 11238649
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
[TBL] [Abstract][Full Text] [Related]
34. Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection.
Onyilagha C; Okwor I; Kuriakose S; Singh R; Uzonna J
Infect Immun; 2014 Mar; 82(3):1074-83. PubMed ID: 24343657
[TBL] [Abstract][Full Text] [Related]
35. The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection.
Schmieder A; Schledzewski K; Michel J; Schönhaar K; Morias Y; Bosschaerts T; Van den Bossche J; Dorny P; Sauer A; Sticht C; Géraud C; Waibler Z; Beschin A; Goerdt S
Eur J Immunol; 2012 Nov; 42(11):2971-82. PubMed ID: 22806454
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
Tansini A; de Medeiros BM
Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
[TBL] [Abstract][Full Text] [Related]
37. Alternative versus classical macrophage activation during experimental African trypanosomosis.
Baetselier PD; Namangala B; Noël W; Brys L; Pays E; Beschin A
Int J Parasitol; 2001 May; 31(5-6):575-87. PubMed ID: 11334945
[TBL] [Abstract][Full Text] [Related]
38. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
Abrahamsohn IA; Coffman RL
J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
[TBL] [Abstract][Full Text] [Related]
39. Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection.
Kuriakose S; Muleme HM; Onyilagha C; Singh R; Jia P; Uzonna JE
PLoS One; 2012; 7(11):e48696. PubMed ID: 23144931
[TBL] [Abstract][Full Text] [Related]
40. Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections.
Magez S; Radwanska M; Drennan M; Fick L; Baral TN; Brombacher F; De Baetselier P
J Infect Dis; 2006 Jun; 193(11):1575-83. PubMed ID: 16652287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
